FeesSafety
Pluang+

U.S. spot Bitcoin ETFs see $8.3B outflows since Oct 2025, average holder cost near $81K per Bitcoin.

Market News
19 Nov 2026, 04:20 WIB
Tokenpost
View Source
Neutral
U.S. spot Bitcoin ETFs see $8.3B outflows since Oct 2025, average holder cost near $81K per Bitcoin.

Since October 2025, U.S. spot Bitcoin ETFs have experienced $8.3 billion in cumulative outflows, following earlier inflows of about $63 billion. The average cost basis for holders is estimated around $81,000 to $82,000 per Bitcoin, a price level that has acted as resistance recently. Investment advisers have become the largest holders, surpassing hedge funds, though advisers sold in Q3 while hedge funds bought. These ETF flows reflect broader market trends and investor behavior, with many holders currently facing unrealized losses.

Spot Bitcoin ETFs show $8.3 billion outflows since October 2025, with an average cost near $81,000. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 19, 2026 08:21 WIB: out of 50 major cryptocurrencies, 8 rose and 40 fell. Notable movers include FIL at Rp10.308 (-6.27%, 6% Sell / 94% Buy), CRV at Rp3.622 (-5.01%, 58% Sell / 42% Buy), and CAKE at Rp28.597 (-4.64%, 77% Sell / 23% Buy).

More News

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic plans IPO to fund AI-driven bioscience, with potential future ties to Ginkgo Bioworks' lab automation.

Anthropic is set to go public on November 19, raising tens of billions to boost its AI capabilities in bioscience, focusing on lab automation and robotics. Ginkgo Bioworks, a leader in automated biotech labs, collaborates with OpenAI but has no curre...

Market News
Bullish
39 minutes ago
BellRing shares jump 24% on strong sales and upbeat earnings forecast

BellRing shares jump 24% on strong sales and upbeat earnings forecast

BellRing Brands saw a 24% surge in its stock price after reporting a 7% increase in net sales to $692 million for fiscal 2026 Q4, driven by strong demand for its high-protein Premier Protein shakes and new product launches like Sparkling Protein Soda...

Company Fundamentals
Bullish
43 minutes ago
Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Analyst cuts Peabody Energy price target by nearly 30% but keeps buy rating.

Freedom Broker analyst Vitaly Kononov lowered Peabody Energy's price target from $30 to $22 per share, citing reduced production outlooks at its key Centurion coal mine and vulnerability in coal prices. Despite the significant cut, he maintained a bu...

Analyst Insights
Bearish
1 hour ago
Micron's strong growth and rising stock price hint at a possible future stock split.

Micron's strong growth and rising stock price hint at a possible future stock split.

Micron Technology is showing strong financial growth, driven by its crucial role in AI infrastructure and multiyear deals with key tech companies. The company recently beat revenue expectations with a 379% year-over-year increase and projects even be...

Company Fundamentals
Bullish
1 hour ago
FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

FDA approves Livsayis™, first siRNA therapy for generalized myasthenia gravis, offering new treatment option.

The FDA has approved Livsayis™ (cemdisiran), the first and only siRNA therapy for adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive. This subcutaneous treatment, administered four times a year, targ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App